Middle East & Africa Cartilage degeneration Market Size, Share, and Analysis by 2027

The Middle East & Africa cartilage degeneration market is expected to reach US$ 511.76 million by 2027 from US$ 426.91 million in 2019; it is estimated to grow at a CAGR of 2.4% from 2020 to 2027.

Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.

Athletes and players frequently suffer due to injuries during sports activities. These injuries have significant potential to damage cartilage and ligaments. An increasing number of sports injuries among players and athletes is anticipated to drive the growth of the cartilage degeneration market during the forecast period. For instance, country-specific annual sports injury rates ranged from 13.5% to 38.1% in males and 5.2% to 20.2% in females in Africa. Over 23 million African adolescents between the ages of 13 and 17 years old sustained at least one serious sports injury over a one-year period. First, the injury incidence due to sports among African adolescents is high, with over 23 million adolescents sustaining at least one serious sports injury over a one-year period. The increasing number of participations in sports leads to the surge in sports injuries among the participants, which will eventually drive the growth of the cartilage degeneration market by 2027.

Countries in Middle East & Africa are facing challenges due to increasing incidences of COVID-19. The COVID-19 pandemic has become the most significant challenge in the region. Africa reported 895,157 cases as of 28 July 2020. The number of growing COVID-19 cases has been reported, such as, South Africa (471,123), Iran (298,909), Israel (68,299) and Kuwait (65,903). Moreover, the other Middle East countries have also been registered a growth in the number of COVID cases in the last few days, with the UAE reaching to 59,921 cases, Saudi Arabia reporting 272,590, and Qatar reaching to 110,153 confirmed cases. A lack of ICU beds and ventilators is common across the region. Apart from this, a huge population already face a growing burden of non-communicable diseases; making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region.

Rest of Middle East & Africa Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Mn)

MIDDLE EAST & AFRICA CARTILAGE DEGENERATION MARKET SEGMENTATION

By Procedure Type

• Joint Replacement
• Chondroplasty
• Cell-based Cartilage Resurfacing
• Osteochondral Transplant
• Meniscus Transplants
• Others

By Application

• Knee
• Hips
• Other

By End User

• Hospitals and Specialty Clinics
• Ambulatory Surgical Centers
• Academic and Research Institutes

By Country

• South Africa
• Saudi Arabia
• UAE
• Rest of Middle East and Africa

Company Profiles

• B. Braun Melsungen AG
• Smith & Nephew
• Stryker Corporation
• CartiHeal, Inc
• Vericel Corporation

Middle East & Africa Cartilage degeneration Report Scope